Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer

Ilya G. Serebriiskii, Valerii A. Pavlov, Grigorii V. Andrianov, Samuel Litwin, Stanley Basickes, Justin Y. Newberg, Garrett M. Frampton, Joshua E. Meyer, Erica A. Golemis

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Somatic PTEN mutations are common and have driver function in some cancer types. However, in colorectal cancers (CRCs), somatic PTEN-inactivating mutations occur at a low frequency (~8–9%), and whether these mutations are actively selected and promote tumor aggressiveness has been controversial. Analysis of genomic data from ~53,000 CRCs indicates that hotspot mutation patterns in PTEN partially reflect DNA-dependent selection pressures, but also suggests a strong selection pressure based on protein function. In microsatellite stable (MSS) tumors, PTEN alterations co-occur with mutations activating BRAF or PI3K, or with TP53 deletions, but not in CRC with microsatellite instability (MSI). Unexpectedly, PTEN deletions are associated with poor survival in MSS CRC, whereas PTEN mutations are associated with improved survival in MSI CRC. These and other data suggest use of PTEN as a prognostic marker is valid in CRC, but such use must consider driver mutation landscape, tumor subtype, and category of PTEN alteration.

Original languageEnglish
Article number40
Pages (from-to)40
Journalnpj Genomic Medicine
Volume8
Issue number1
DOIs
StatePublished - Nov 24 2023

Fingerprint

Dive into the research topics of 'Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer'. Together they form a unique fingerprint.

Cite this